Zantac Heartburn Medication Users File Federal Class Action Lawsuit Complaint Against Various Zantac Manufacturers and Distributors.
Individuals who took the antacid and heartburn drug Zantac have reportedly filed a class action lawsuit in the United States District Court for the Southern District of Ohio (styled Antoine Dodson, et al v. Sanofi S.A., Sanofi-Aventis U.S. LLC, Sanofi US Services Inc., Chattem Inc., Boehringer Ingelheim Pharmaceuticals, Inc., and GlaxoSmithKline, LLC, Case No. 2:20-cv-00356-GCS-KAJ) alleging, among other things, that they have been subjected to an increased risk of contracting cancer as a result of their prolonged exposure to Zantac products.
According to the Zantac complaint, the antacid may have been contaminated with NDMA, a semivolatile chemical that is considered a probable human carcinogen.
The proposed Zantac class action lawsuit is reportedly brought on behalf of the following nationwide putative class members:
“All persons within the United States who took the drug Zantac and
who do not have a diagnosis of cancer that has been attributed to
Zantac as of the filing of this complaint.”
The Zantac class action lawsuit complaint reportedly asserts causes of action for, among other things, manufacturing, marketing, selling and distributing an alleged defective product and for alleged negligence.
The Plaintiffs and the putative class members in the Zantac class action law suit reportedly seek, among other things, an order certifying the case as a class action pursuant to Federal Rule of Civil Procedure 23, establishment of a medical monitoring program, the establishment of a science board to conduct additional research on the future impact of Zantac on members of the class in order to improve the effectiveness of the medical monitoring program, and an award of attorneys’ fees and costs to counsel for Plaintiffs and the Class.
Various Zantac lawsuits filed in federal district courts (both individal cases and class action cases) have been consolidated and/or transferred into a multi district litigation in the U.S. District Court, Southern District of Florida, styled In Re Zantac (Ranitidine) Products Liability Litigation, MDL Case No. 2924.
If You Have Thoughts On The Zantac Class Action Lawsuit, Share Your Zantac Class Action Lawsuit Comments Below.